Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs
Melissa P. Lokugamage, Daryll Vanover, Jared Beyersdorf, et al.
Nature Biomedical Engineering (2021) Vol. 5, Iss. 9, pp. 1059-1068
Open Access | Times Cited: 324

Showing 1-25 of 324 citing articles:

Drug delivery systems for RNA therapeutics
Kalina Paunovska, David Loughrey, James E. Dahlman
Nature Reviews Genetics (2022) Vol. 23, Iss. 5, pp. 265-280
Open Access | Times Cited: 832
The role of lipid components in lipid nanoparticles for vaccines and gene therapy
Camilla Hald Albertsen, Jayesh A. Kulkarni, Dominik Witzigmann, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114416-114416
Open Access | Times Cited: 607
The clinical progress of mRNA vaccines and immunotherapies
Ann Barbier, Allen Yujie Jiang, Peng Zhang, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 6, pp. 840-854
Open Access | Times Cited: 501
Chemistry of Lipid Nanoparticles for RNA Delivery
Yulia Eygeris, Mohit Gupta, Jeonghwan Kim, et al.
Accounts of Chemical Research (2021) Vol. 55, Iss. 1, pp. 2-12
Closed Access | Times Cited: 495
mRNA-based cancer therapeutics
Chuang LIU, Qiangqiang Shi, Xiangang Huang, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 8, pp. 526-543
Closed Access | Times Cited: 227
Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy
Yan Zong, Yi Lin, Tuo Wei, et al.
Advanced Materials (2023) Vol. 35, Iss. 51
Closed Access | Times Cited: 187
Lipid Nanoparticle–mRNA Formulations for Therapeutic Applications
Chang Wang, Yuebao Zhang, Yizhou Dong
Accounts of Chemical Research (2021) Vol. 54, Iss. 23, pp. 4283-4293
Open Access | Times Cited: 153
Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing
Bowen Li, Rajith S. Manan, Shun‐Qing Liang, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 10, pp. 1410-1415
Open Access | Times Cited: 152
Engineering Lipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through Inhalation
Jeonghwan Kim, Antony Jozić, Yuxin Lin, et al.
ACS Nano (2022) Vol. 16, Iss. 9, pp. 14792-14806
Open Access | Times Cited: 142
Non-liver mRNA Delivery
David Loughrey, James E. Dahlman
Accounts of Chemical Research (2021) Vol. 55, Iss. 1, pp. 13-23
Closed Access | Times Cited: 116
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
Jilian R. Melamed, Saigopalakrishna S. Yerneni, Mariah L. Arral, et al.
Science Advances (2023) Vol. 9, Iss. 4
Open Access | Times Cited: 100
Species-agnostic polymeric formulations for inhalable messenger RNA delivery to the lung
Laura Rotolo, Daryll Vanover, Nicholas C. Bruno, et al.
Nature Materials (2022) Vol. 22, Iss. 3, pp. 369-379
Open Access | Times Cited: 98
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
Michaela Jeong, Yeji Lee, Jeongeun Park, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 114990-114990
Closed Access | Times Cited: 97
mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells
Sanne Bevers, Sander A.A. Kooijmans, Elien Van de Velde, et al.
Molecular Therapy (2022) Vol. 30, Iss. 9, pp. 3078-3094
Open Access | Times Cited: 91
Multi-step screening of DNA/lipid nanoparticles and co-delivery with siRNA to enhance and prolong gene expression
Yining Zhu, Ruochen Shen, Ivan Vuong, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 86
The use of RNA-based treatments in the field of cancer immunotherapy
Mohammad Chehelgerdi, Matin Chehelgerdi
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 86
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability
Lizhou Zhang, Kunal R. More, Amrita Ojha, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 86
Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination
Alexandra Suberi, Molly K. Grun, Tianyang Mao, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 709
Open Access | Times Cited: 85
Drug delivery systems for CRISPR-based genome editors
Victoria J. Madigan, Feng Zhang, James E. Dahlman
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 11, pp. 875-894
Closed Access | Times Cited: 80
Quality by Design for enabling RNA platform production processes
Simon Daniel, Zoltán Kis, Cleo Kontoravdi, et al.
Trends in biotechnology (2022) Vol. 40, Iss. 10, pp. 1213-1228
Open Access | Times Cited: 79
Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics
Ellenmae W. X. Leong, Ruowen Ge
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2179-2179
Open Access | Times Cited: 74
Nanotechnology-based mRNA vaccines
Shuying Chen, Xiangang Huang, Yonger Xue, et al.
Nature Reviews Methods Primers (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 74
Clinical delivery of circular RNA: Lessons learned from RNA drug development
Tiana L. Young, Kevin Chang Wang, Andrew Varley, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114826-114826
Closed Access | Times Cited: 72
Current challenges and future directions for engineering extracellular vesicles for heart, lung, blood and sleep diseases
Guoping Li, Tianji Chen, James E. Dahlman, et al.
Journal of Extracellular Vesicles (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 70
Lipid nanoparticles for siRNA delivery in cancer treatment
Souhaila H. El Moukhtari, Elisa Garbayo, Ane Amundarain, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 130-146
Closed Access | Times Cited: 69
Page 1 - Next Page

Scroll to top